Steven Patterson, MD
General Surgery · Jackson, MSNPI 1467551341
Payments from drug & device makers
What this record shows
This record is dominated by education: $9,500 of the $13,923 with a category attached, or 68.2%. Intuitive Surgical accounts for 73.8% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $8,723 and has fallen 90.4% since, to $835 in 2025.
Across 189 payments — averaging $73.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- AbbVie$1K
- Myriad Genetic Laboratories, Inc.$398
- Takeda Pharmaceuticals U.S.A., Inc.$390
- Medtronic$251
- TELA Bio, Inc.$216
- plus $1K from 31 others
What the payments were for
- Food & beverage$4,42332%
- Education$9,50068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $10,275 |
| AbbVie(2 entities) | 57 | $1,021 |
| Myriad Genetic Laboratories, Inc. | 15 | $398 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $390 |
| Medtronic | 3 | $251 |
| TELA Bio, Inc. | 11 | $216 |
| Johnson & Johnson | 6 | $177 |
| Hologic Sales And Service, LLC | 4 | $139 |
| Vertex | 5 | $87 |
| CSL Behring | 4 | $87 |
| Innovation Technologies Inc | 3 | $76 |
| Baxter Healthcare | 4 | $75 |
| Shire North American Group Inc | 5 | $66 |
| Boston Scientific | 3 | $63 |
| Hydrofera LLC | 2 | $53 |
| Conmed Corporation | 2 | $48 |
| Merck | 2 | $46 |
| Integra Lifesciences Corporation | 2 | $42 |
| Innocoll Pharmaceuticals Limited | 2 | $41 |
| Davol Inc. | 2 | $41 |
| Lucid Diagnostics Inc. | 2 | $32 |
| Carl Zeiss Meditec, Inc. | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Smith+Nephew | 2 | $31 |
| Heron Therapeutics, Inc. | 2 | $28 |
| Pfizer | 1 | $23 |
| Convatec Inc. | 1 | $19 |
| Trevena, Inc. | 1 | $17 |
| Misonix Inc | 1 | $16 |
| Reprise Biomedical, Inc. | 1 | $16 |
| Organogenesis Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
| Coopersurgical, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $14 |
| Somavac Medical Solutions, Inc. | 1 | $13 |
| KCI USA, Inc. | 1 | $13 |
| Bolder Surgical LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,521
- DAVINCI XI$1,500
- Symbotex$130
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$123
How this compares
Too few general surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 14 | $1,229,978 |
| EliquisApixaban | 25 | $13,593 |
| JanuviaSitagliptin Phosphate | 11 | $4,954 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $1,048 |
| Tamoxifen Citrate | 40 | $769 |
| Ciprofloxacin Hcl | 44 | $371 |
| Ondansetron OdtOndansetron | 16 | $332 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $275 |
| Hydralazine Hcl | 21 | $201 |
| Potassium Chloride | 32 | $197 |
| Metronidazole | 12 | $194 |
| Levothyroxine Sodium | 19 | $178 |
| Omeprazole | 28 | $147 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $123 |
| Lorazepam | 12 | $120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $390 | $1,229,97814 claims |
| PfizerEliquis | $23 | $13,59325 claims |
| MerckJanuvia | $46 | $4,95411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few general surgery providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other general surgery in Jackson
- Patrick ScanlonJackson$10K
- James ChandlerJackson$7K
- Richard YelvertonJackson$5K
- Christopher LahrJackson$0
- Geoffrey FlattmannNatchez$26K
- David RimmerBay St Louis$2K
- Philip DoolittleGreenville$0
- Jeffery DoolittleGreenville$0
- Jaiyeola AdeleyeClarksdale$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.